Authors:
Zurbrugg, HR
Musci, M
Sanger, S
Gutersohn, A
Mulling, C
Wellnhofer, E
Schaffner, T
Hetzer, R
Citation: Hr. Zurbrugg et al., Prevention of venous graft sclerosis with clopidogrel and aspirin combinedwith a mesh tubing in a dog model of arteriovenous bypass grafting, EUR J VAS E, 22(4), 2001, pp. 337-341
Authors:
Fielitz, J
Hein, S
Mitrovic, V
Pregla, R
Zurbrugg, HR
Warnecke, C
Schaper, J
Fleck, E
Regitz-Zagrosek, V
Citation: J. Fielitz et al., Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease, J AM COL C, 37(5), 2001, pp. 1443-1449
Authors:
Kupfahl, C
Pink, D
Friedrich, K
Zurbrugg, HR
Neuss, M
Warnecke, C
Fielitz, J
Graf, K
Fleck, E
Regitz-Zagrosek, V
Citation: C. Kupfahl et al., Angiotensin II directly increases transforming growth factor beta 1 and osteopontin and indirectly affects collagen mRNA expression in the human heart, CARDIO RES, 46(3), 2000, pp. 463-475
Authors:
Zurbrugg, HR
Knollmann, F
Musci, M
Wied, M
Bauer, M
Chavez, T
Krukenberg, A
Hetzer, R
Citation: Hr. Zurbrugg et al., The biocompound method in coronary artery bypass operations: Surgical technique and 3-year patency, ANN THORAC, 70(5), 2000, pp. 1536-1540
Authors:
Spruth, E
Zurbrugg, HR
Warnecke, C
Erdmann, J
Pregla, R
Pfautsch, P
Hetzer, R
Fleck, E
Regitz-Zagrosek, V
Citation: E. Spruth et al., Expression of ACE mRNA in the human atrial myocardium is not dependent on left ventricular function, ACE inhibitor therapy, or the ACE I/D genotype, J MOL MED-J, 77(11), 1999, pp. 804-810